肝脏超声造影诊断肝癌术后肝内肿瘤复发的价值探讨

doi:10.3969/j.issn.1672-5069.2016.02.024

Abstract

Wang Wenjuan, Bai Mei, Cai Jiangtao. Contrast-enhanced ultrasonography in the diagnosis of intrahepatic tumor recurrence in patients with hepatocellular carcinoma after hepatectomy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(2): 214-216.

References

[1] Honjo M,Moriyasu F,Sugimoto K,et al. Relationship between the liver tissue shear modulus and histopathologic findings analyzed by intraoperative shear wave elastography and digital microscopically assisted morphometry in patients with hepatocellular carcinoma. J Ultrasound Med,2014,33（1）:61-71.
[2] Cha MJ,Lee MW,Cha DI,et al. Size discrepancy between sonographic and computed tomographic/magnetic resonance imaging measurement of hepatocellular carcinoma:the necessity of tumor size measurement standardization. J Ultrasound Med, 2013,32（10）:1703-1709.
[3] 周伟平,尹磊,吴孟超,等. 抗病毒治疗在HBV相关肝癌综合治疗中的作用. 实用肝脏病杂志,2015,18（2）:115-117.
[4] Huang S,Yu J,Liang P,et al. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels:A long-term follow-up. Eur J Radiol,2014,83（3）:552-558.
[5] 王松贤. 慢性乙型肝炎患者肝组织学检查的意义.实用肝脏病杂志,2014,17（3）:297-298.
[6] Numata K, Fukuda H,Miwa H,et al. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. Eur J Radiol, 2014,83（1）:95-102.
[7] Numata K,Fukuda H,Miwa H,et al. Contrast-enhanced ultrasonography findings using a perflubutane-based contrast agent in patients with early hepatocellular carcinoma. Eur J Radiol, 2014,83（1）:95-102.
[8] Zhu J,Zhu H,Mei Z,et al. High-intensity focused ultrasound ablation for treatment of hepatocellular carcinoma andhypersplenism:preliminary study. J Ultrasound Med,2013,32（10）:1855-1862.
[9] Choi JI, Jung SE,Kim PN,et al. Quality assurance in ultrasound screening for hepatocellular carcinoma using a standardized phantom and standard clinical images:A 3-year national investigation in Korea. J Ultrasound Med,2014,33（6）:985-995.
[10] Takizawa K,Numata K,Morimoto M,et al. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma. Eur J Radiol,2013,82（9）:1471-1480.
[11] Niu Y,Huang T,Lian F,et al. Contrast-enhanced ultrasonography for the diagnosis of small hepatocellular carcinoma:A meta-analysis and meta-regression analysis. Tumour Biol,2013, 34（6）:3667-3674.
[12] Wang L,Yao M,Dong Z,et al. Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring. Tumour Biol,2014,35（1）:9-20.
[13] Frampas E,Lassau N,Zappa M,et al. Advanced hepatocellular carcinoma:Early evaluation of response to targeted therapy and prognostic value of perfusion CT and dynamic contrast enhanced-ultrasound. Eur J Radiol,2013,82（5）:e205-e211.
[14] 崔贤,李开艳,张喜君,等.超声造影在肝癌术后患者中早期诊断复发的应用. 中国超声医学杂志,2011,27（6）:539-542.
[15] Sato K,Tanaka S,Mitsunori Y,et al. Contrast-enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma:Clinical and biological significance. Hepatology, 2013,57（4）:1436-1447.
[16] Kita R,Sakamoto A,Nagata Y,et al. Visualization of blood drainage area from hypervascular hepatocellular carcinoma on ultrasonographic images during hepatic arteriogram:Comparison with depiction of drainage area on contrast-enhanced ultrasound. Hepatol Res,2012,42（10）:999-1007.
[17] Kazue S,Manabu W. Usefulness of contrast-enhanced ultrasonography in the diagnosis of ruptured hepatocellular carcinoma. Clin J Gastroenterol,2013,6（4）:334-337.
[18] Arii S,Tanaka S,Mitsunori Y,et al. Surgical strategies for hepatocellular carcinoma with special reference to anatomical hepatic resection and intraoperative contrast-enhanced ultrasonography. Oncology,2010,78（Suppl 1）:125-130.

Contrast-enhanced ultrasonography in the diagnosis of intrahepatic tumor recurrence in patients with hepatocellular carcinoma after hepatectomy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Ye Xianjun, He Nian’an, Sui Xiufang, et al.. Contrast-enhanced ultrasonographic features of hepatic epitheloid hemangioendothelioma [J]. Journal of Practical Hepatology, 2019, 22(6): 904-907.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[11]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[12]	Qiu Jun, Wang Xueqing, Zhang Bo, et al. Percutaneous choledocholithotomy for the treatment of patients with intrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2019, 22(5): 744-747.
[13]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[14]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[15]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.